Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Stem cell transplantation for non-malignant disorders.

C G Steward1

  • 1Bristol Royal Hospital for Sick Children, UK.

Bailliere'S Best Practice & Research. Clinical Haematology
|October 13, 2000
PubMed
Summary

Stem cell transplantation (SCT) offers curative potential for various non-malignant diseases, including blood disorders and autoimmune conditions. However, significant toxicities and complications like graft-versus-host disease (GvHD) persist, necessitating ongoing research and technological advancements.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correlation between microsatellite discrepancy scores and transplant outcome after haemopoietic SCT for pediatric ALL.

Bone marrow transplantation·2015
Same author

Barth syndrome: an X-linked cause of fetal cardiomyopathy and stillbirth.

Prenatal diagnosis·2010
Same author

Hematopoietic cell transplantation for Chediak-Higashi syndrome.

Bone marrow transplantation·2007
Same author

Haemopoietic stem cell transplantation for genetic disorders.

Archives of disease in childhood·2005
Same author

Bone marrow transplantation correcting beta-galactosidase activity does not influence neurological outcome in juvenile GM1-gangliosidosis.

Journal of inherited metabolic disease·2005
Same author

Rotavirus as a significant cause of prolonged diarrhoeal illness and morbidity following allogeneic bone marrow transplantation.

Bone marrow transplantation·2005

Area of Science:

  • Hematology
  • Immunology
  • Genetics

Background:

  • Stem cell transplantation (SCT) is a therapeutic approach for numerous non-malignant disorders.
  • These include inherited blood cell defects, metabolic diseases requiring in vivo enzyme replacement, and severe autoimmune conditions.

Purpose of the Study:

  • To review the indications for SCT in non-malignant diseases.
  • To present outcome statistics and discuss inherent challenges.
  • To explore the impact of technological advancements and emerging therapies like enzyme and gene therapy.

Main Methods:

  • Review of scientific literature and clinical data pertaining to SCT for non-malignant diseases.
  • Analysis of treatment outcomes and complications, including graft-versus-host disease (GvHD).

Related Experiment Videos

  • Evaluation of technological improvements and the potential of enzyme and gene therapies.

    • Main Results:

    • SCT has revolutionized treatment for many non-malignant diseases, offering cures or significant amelioration.
    • Severe toxicities, often related to conditioning regimens or post-transplant complications like GvHD, remain a challenge.
    • Technological advancements in the 1990s have improved outcomes, with enzyme and gene therapies showing future promise.

    Conclusions:

    • Stem cell transplantation is a vital treatment modality for a spectrum of non-malignant diseases.
    • Addressing treatment-related toxicities and complications is crucial for optimizing SCT outcomes.
    • Continued innovation, including enzyme and gene therapies, holds potential for further enhancing SCT efficacy and safety.